Healthcare Innovation

Velo Med Spa introduces a revolutionary non-surgical body contouring solution using donor-derived tissue, promising natural results without the knife.

The medical device firm reports 20% Q1 revenue growth, fueled by new billing codes that boost Barostim approvals and a trial to triple its patient base.

A group known for challenging pandemic rules will now advise on US vaccine policy. Can it rebuild trust, or will it deepen the medical divide?

Microsoft's health tech COO joins OptimizeRx's board, signaling a major push into AI-driven platforms and a new phase of strategic growth for the company.

Retired NASA astronaut and UMD alumna Dr. Jeanette Epps will inspire the Class of 2026, bringing her story of 'fearless determination' back to campus.

A new alliance between Daiichi Sankyo and ATLATL aims to leverage a unique 'Super Server' model to fast-track novel therapies from Asia to the world.

For a second year, ABA Centers ranks among the Americas' fastest-growing firms, tackling the autism care crisis with a disruptive, no-waitlist model.

A landmark case could strip healthcare giants of a key legal defense, holding them accountable for allegedly deceiving seniors into for-profit Medicare plans.

A new federal grant positions Connecticut's HIE to solve a major privacy hurdle, testing tech that could transform care for SUD patients nationwide.

Landmark study results show a new drug-coated balloon significantly improves outcomes for Peripheral Artery Disease, heralding a major shift in treatment.

HealthEquity adds Sanford Health CEO Bill Gassen to its board, a strategic move to infuse provider-side expertise into the HSA giant's future.

Tenpoint Therapeutics launches YUVEZZI, a once-daily drop for presbyopia, entering a fierce market with a novel two-in-one formula for aging eyes.

Growth equity firm SEMCAP launches a new fund with Unilever Prestige visionary Vasiliki Petrou, targeting the booming wellness and longevity market.

Ephicacy appoints biometrics SVP Jamie Powers and India Head Tyagi Swaminathan in a strategic push to dominate advanced clinical trial analytics.

Pharma giant Sanofi inks a massive deal for Kali Therapeutics' KT501, a novel T-cell engager aiming to reset the immune system in autoimmune diseases.

A new book by a top physician-scientist challenges the idea that innovation comes from the private sector, arguing Medicaid is a lab for bold experiments.

Annovis Bio's new trial for buntanetap uses an AI-powered Apple Watch app to track symptoms, aiming for more precise data in the race for a cure.

The deal, part of a broader consolidation strategy by parent The Lockwood Group, aims to meet rising pharma demand for advanced data and patient services.

A new injectable dye entering Phase 3 trials promises to make lung cancer cells glow, helping surgeons remove tumors more completely and prevent recurrence.

JAMP Pharma Group introduces a generic version of a key prostate cancer drug, aiming to reduce healthcare costs and enhance patient support in Canada.